Best Practices to Prevent COVID-19 Illness in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living Settings

NACompletedINTERVENTIONAL
Enrollment

415

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

November 30, 2022

Study Completion Date

November 30, 2022

Conditions
Intellectual DisabilityDevelopmental DisabilityAxis I DiagnosisMental IllnessCovid19Coronavirus
Interventions
BEHAVIORAL

Generic Best Practices

GBP consists of (1) Massachusetts Executive Office of Health and Human Services distribution of standard guidelines and policies for public health prevention and management of COVID and (2) standard virtual training of the staff of the group homes in these generic COVID-19 prevention practices including recommended use of hand washing, use of PPE, and symptom-triggered screening. Group homes randomized to this intervention will receive standard recommended and fully vetted best practices with respect to preventing and managing COVID-19 based on recommendations by the CDC and on consultation with leading national experts in infectious disease working with the Commonwealth of Massachusetts. The control condition does not represent inferior or substandard practice. As findings occur and as policy leads to adjustments in recommendations during the course of the study, the GBP condition will incorporate recommendations that are appropriate and up-to-date with CDC and state policy.

BEHAVIORAL

Tailored Best Practices

TBP consists of optimized, tailored, and highly specific COVID-19 best practices and training materials specific to the setting, staff, and residents with SMI and ID/DD in congregate living settings based on the comparative effectiveness of different types, intensities, and combinations of COVID-19 prevention practices (screening, isolation, contact tracing, use of PPP, vaccination) specifically modeled for residents and staff of congregate living settings for people with ID/DD and SMI derived by a simulation model. Results from this modeling process will be provided to stakeholders to support decision makers in prioritizing resources and practices with the greatest impact on reducing COVID-19 tailored for people with SMI and ID/DD in congregate living settings. This process to determine the content of TBP will occur as part of this study prior to randomization.

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Patient-Centered Outcomes Research Institute

OTHER

collaborator

Advocates

UNKNOWN

collaborator

Bay Cove Human Services

OTHER

collaborator

North Suffolk Mental Health Association

OTHER

collaborator

Open Sky Community Services

UNKNOWN

collaborator

Riverside Community Care, Inc.

UNKNOWN

collaborator

Dartmouth College

OTHER

collaborator

Vinfen

INDUSTRY

lead

Massachusetts General Hospital

OTHER

NCT04726371 - Best Practices to Prevent COVID-19 Illness in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living Settings | Biotech Hunter | Biotech Hunter